Selective Retina Therapy (SRT) in Patients With Idiopathic Central Serous Retinopathy

Key facts

Sponsor

University of Kiel

Principal Investigator

Johann J Roider, Professor

Department of Ophthalmology University of Kiel

Intervention

Selective Retina Therapy (SRT)(device)

Enrollment

30 enrolled

Eligibility

All sexes

Timeline

2007 – 2009

Study locations (1)

• Department of Ophthalmology, Kiel, Schleswig-Holstein, Germany

Collaborators

Medical Laser Center Lübeck, Lübeck, Germany · Institute for Medical Informaties and Statistics Kiel, Germany

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Central serous chorioretinopathy

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT06527326
  the Study of the Association Between the Gut Microbiota and Central Serous Chorioretinopathy
  Second Affiliated Hospital, School of Medicine, Zhejiang University
• RECRUITINGNCT06346405
  Central Serous Chorioretinopathy and Micropulse Laser Treatment
  Fondazione Policlinico Universitario Agostino Gemelli IRCCS
• RECRUITINGNANCT05570591
  Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy
  Nova Eye Medical Pty Ltd.
• RECRUITINGNCT05589974
  Choroidal Blood Flow in Acute and Chronic Central Serous Chorioretinopathy
  Helse Stavanger HF

See all trials for Central serous chorioretinopathy →